• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MChip, a low density microarray, differentiates among seasonal human H1N1, North American swine H1N1, and the 2009 pandemic H1N1

tetano

Editor, Senior Moderator
MChip, a low density microarray, differentiates among seasonal human H1N1, North American swine H1N1, and the 2009 pandemic H1N1

1. Gary L. Heil1,
2. Troy McCarthy2,
3. Kyoung-Jin Yoon3,
4. Siyuan Liu3,
5. Magdi D. Saad4,
6. Catherine B. Smith5,
7. Julie A. Houck6,
8. Erica D. Dawson7,
9. Kathy L. Rowlen7,
10. Gregory C. Gray1

Article first published online: 19 OCT 2010

DOI: 10.1111/j.1750-2659.2010.00185.x

Background  The MChip uses data from the hybridization of amplified viral RNA to 15 distinct oligonucleotides that target the influenza A matrix (M) gene segment. An artificial neural network (ANN) automates the interpretation of subtle differences in fluorescence intensity patterns from the microarray. The complete process from clinical specimen to identification including amplification of viral RNA can be completed in <8 hours for under US$10.

Objectives  The work presented here represents an effort to expand and test the capabilities of the MChip to differentiate influenza A/H1N1 of various species origin.

Methods  The MChip ANN was trained to recognize fluorescence image patterns of a variety of known influenza A viruses, including examples of human H1N1, human H3N2, swine H1N1, 2009 pandemic influenza A H1N1, and a wide variety of avian, equine, canine, and swine influenza viruses. Robustness of the MChip ANN was evaluated using 296 blinded isolates.

Results  Training of the ANN was expanded by the addition of 71 well-characterized influenza A isolates and yielded relatively high accuracy (little misclassification) in distinguishing unique H1N1 strains: nine human A/H1N1 (88?9% correct), 35 human A/H3N2 (97?1% correct), 31 North American swine A/H1N1 (80?6% correct), 14 2009 pandemic A/H1N1 (87?7% correct), and 23 negative samples (91?3% correct). Genetic diversity among the swine H1N1 isolates may have contributed to the lower success rate for these viruses.

Conclusions  The current study demonstrates the MChip has the capability to differentiate the genetic variations among influenza viruses with appropriate ANN training. Further selective enrichment of the ANN will improve its ability to rapidly and reliably characterize influenza viruses of unknown origin.

http://onlinelibrary.wiley.com/doi/...ionid=395343657894C36B65D554ACCE2EC4F3.d01t02
 
Back
Top Bottom